Trial Profile
A Randomized Pilot Study of Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2022
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary) ; Buprenorphine/naloxone
- Indications Opioid-related disorders
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2022 Planned initiation date changed from 1 Sep 2020 to 1 Jun 2022.
- 01 Jun 2022 Status changed from suspended to discontinued as funding for uninsured subjects could not be realized and staffing after COVID hit was also a problem.
- 10 Jun 2021 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.